Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.807 USD | 0.00% | +4.67% | +41.58% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Neutral |
Resistance | 0.9446 | 1.170 | 1.580 |
Spread/Res. | -14.57% | -31.03% | -48.92% |
Spread/Supp. | +15.29% | +15.29% | +73.03% |
Support | 0.7000 | 0.7000 | 0.4664 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- VIRX Stock
- Charts Viracta Therapeutics, Inc.